Skip to main content


The Center for Population-Level Bioethics (CPLB) is dedicated to the study of macro-level bioethical dilemmas: those that arise outside the clinical encounter, at the level of the population, the state, the country, or the globe. Questions of interest range from the theoretical to the applied, for example how to conceptualize, measure and evaluate health inequalities or disease severity; how to prioritize resources between disease areas, rural and urban patients, and age cohorts or generations; the acceptability of paternalistic health promotion measures; and many others.

Learn More


Dr. Daniel Hausman, the 2023-2024 Baruch A. Brody Lecture award recipient

26 Feb 2024

Dr. Hausman, attended the award presentation and lecture on Monday, Feb. 26, 2024. Dr. Hausman presented his lecture on "Preferences, Health and Healthcare." A recording of this lecture will be made available in the near future...

Read More

Eyal and Lerner published a joint paper in “Journal of Medical Ethics”

29 Jan 2024

CPLB post-doctoral associate Adam Lerner and CPLB Director Nir Eyal recently published “Future pandemics and the urge to ‘do something’” in the Journal of Medical Ethics. The paper intervenes in an ongoing debate about research with...

Read More

Dr. Emma J. Curran joins CPLB as a Postdoctoral Associate

30 Oct 2023

Dr. Curran received her PhD in Philosophy from Trinity Hall, University of Cambridge and MPhil in Philosophy from the University of Cambridge. Earlier, gained her BSc Philosophy, Logic and Scientific Method at the London School of Economics...

Read More

VIDEO: The Ethical Imperative: Global Vaccine Equity

12 May 2021

On May 12, 2021 the Center for Population-Level Bioethics and co-sponsors 1Day Sooner and the Institute for Health hosted experts for a discussion of vaccine availability around the world, and to launch an open letter to the World Health Organization asking it to put several vaccine measures up to a vote in its upcoming World Health Assembly. The letter was led by veterans of the response to the 2014 Ebola outbreak.

Read More